文献速递瓣膜病与结构性心脏病

门诊主动脉瓣狭窄严重程度与死亡率的相关性:VALVENOR 研究结果

Association of Mortality With Aortic Stenosis Severity in Outpatients: Results From the VALVENOR Study.
PubMed 文献 · JAMA Cardiol · 2021-01-01

VALVENOR 研究在法国 Nord-Pas-de-Calais 地区由 117 位心内科医生连续纳入 2703 例门诊原生主动脉瓣狭窄患者,按超声峰值流速分为轻度、中度、重度。中位随访 2.1 年,634 例接受主动脉瓣置换,448 例在置换前死亡,多数为心血管死亡。与轻度狭窄相比,中度和重度狭窄心血管死亡率分别升高(HR 1.47 和 3.66),无症状患者中中度与轻度狭窄心血管死亡率相似。

要点

  • 门诊主动脉瓣狭窄患者中,重度狭窄心血管死亡风险显著高于轻度(HR 3.66)。
  • 中度狭窄心血管死亡风险略高于轻度(HR 1.47),但远低于重度。
  • 无症状患者中,中度与轻度狭窄心血管死亡率相似(HR 0.99)。

核心结论

  • 中度主动脉瓣狭窄患者心血管死亡风险略高于轻度,但远低于重度狭窄。
  • 无症状患者中,中度与轻度主动脉瓣狭窄心血管死亡率相似。

研究设计与样本

  • 2016 年 5 月至 2017 年 12 月,法国 Nord-Pas-de-Calais 地区 117 位心内科医生连续纳入 2703 例门诊原生主动脉瓣狭窄患者。
  • 按超声峰值流速分级:轻度 2.5-2.9 m/s(1154 例,42.7%),中度 3-3.9 m/s(1122 例,41.5%),重度 ≥4 m/s(427 例,15.8%)。
  • 患者平均(SD)年龄 76.0(10.8)岁,女性 1260 例(46.6%);233 例(8.6%)来自大学公立医院,757 例(28%)来自非大学公立医院,1713 例(63.4%)由私人执业心内科医生纳入。

主要发现

  • 中位(四分位距)随访 2.1(1.4-2.7)年,634 例接受主动脉瓣置换,448 例在置换前死亡。
  • 死亡者中,心血管死亡 200 例(44.7%),主要与充血性心力衰竭(101 例,22.6%)或猝死(60 例,13.4%)相关;非心血管死亡 186 例(41.5%),原因不明 62 例(13.8%)。
  • 与轻度狭窄相比,中度狭窄心血管死亡风险比 1.47(95%CI 1.07-2.02),重度狭窄风险比 3.66(95%CI 2.52-5.31)。
  • 调整基线特征或考虑狭窄进展的时间依赖分析后,差异仍显著。
  • 无症状患者中,中度与轻度狭窄心血管死亡风险比 0.99(95%CI 0.44-2.21)。

临床怎么用

  • 门诊评估主动脉瓣狭窄时,应按超声峰值流速明确分级并关注心血管死亡风险。
  • 重度狭窄患者心血管死亡风险显著增高,需按指南评估主动脉瓣置换指征。
  • 无症状中度狭窄患者心血管死亡风险与轻度相似,可密切随访而非急于干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Modern data regarding incidence and modes of death of patients with aortic stenosis (AS) are restricted to tertiary centers or studies of aortic valve replacement (AVR). OBJECTIVE: To provide new insights into the natural history of outpatients with native AS based on a large regionwide population study with inclusion by all cardiologists regardless of their mode of practice. DESIGN, SETTING, AND PARTICIPANTS: Between May 2016 and December 2017, consecutive outpatients with mild (peak aortic velocity, 2.5-2.9 m/s), moderate (peak aortic velocity, 3-3.9 m/s), and severe (peak aortic velocity, ≥4 m/s) native AS graded by echocardiography were included by 117 cardiologists from the Nord-Pas-de-Calais region in France. Analysis took place between August and November 2020. MAIN OUTCOMES AND MEASURES: Natural history, need for AVR, and survival of patients with AS were followed up. Indications for AVR were based on current guideline recommendations. RESULTS: Among 2703 patients (mean [SD] age, 76.0 [10.8] years; 1260 [46.6%] women), 233 (8.6%) were recruited in a university public hospital, 757 (28%) in nonuniversity public hospitals, and 1713 (63.4%) by cardiologists working in private practice. A total of 1154 patients (42.7%) had mild, 1122 (41.5%) had moderate, and 427 (15.8%) had severe AS. During a median (interquartile range) of 2.1 (1.4-2.7) years, 634 patients underwent AVR and 448 died prior to AVR. Most deaths were cardiovascular (200 [44.7%]), mainly associated with congestive heart failure (101 [22.6%]) or sudden death (60 [13.4%]). Deaths were noncardiovascular in 186 patients (41.5%) and from unknown causes in 62 patients (13.8%). Compared with patients with mild AS, there was increased cardiovascular mortality in those with moderate (hazard ratio, 1.47 [95% CI, 1.07-2.02]) and severe (hazard ratio, 3.66 [95% CI, 2.52-5.31]) AS. The differences remained significant when adjusted for baseline characteristics or in time-dependent analyses considering AS progression. In asymptomatic patients, moderate and mild AS were associated with similar cardiovascular mortality (hazard ratio, 0.99 [95% CI, 0.44-2.21]). CONCLUSIONS AND RELEVANCE: While patients in this study with moderate AS had a slightly higher risk of cardiovascular death than patients with mild AS, this risk was much lower than that observed in patients with severe AS. Moreover, in asymptomatic patients, moderate and mild AS were associated with similar cardiovascular mortality.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Coisne A, Montaigne D, Aghezzaf S, et al. Association of Mortality With Aortic Stenosis Severity in Outpatients: Results From the VALVENOR Study. JAMA Cardiol. 2021. PMID: 34586336. doi:10.1001/jamacardio.2021.3718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。